依达拉奉联合尤瑞克林治疗急性脑梗塞效果探讨
2015-01-31杨洁
杨洁
依达拉奉联合尤瑞克林治疗急性脑梗塞效果探讨
杨洁
【摘要】目的 探讨依达拉奉联合尤瑞克林治疗急性脑梗塞临床疗效。方法 对照组经常规治疗基础上加用依达拉奉;研究组在常规治疗基础上给予依达拉奉+尤瑞克林联合治疗,记录分析两组患者临床疗效。结果 两组急性脑梗塞患者经不同方法治疗后,研究组临床治疗总有效率82.22%高于对照组66.67%,P>0.05,差异具有统计学意义。结论在常规治疗基础上加用依达拉奉与尤瑞克林联合治疗后可显著提高急性脑梗塞临床疗效,有利于降低患者致残率及死亡率,保障其生活质量及生命安全。
【关键词】急性脑梗塞;依达拉奉;尤瑞克林;治疗效果
作者单位:453000河南省新乡市第一人民医院重症医学科
To Explore the Clinical Effect of Edaravone Combine With Urinary Kallidinogenase Treatment Acute Cerebral Infarction
YANG Jie Xinxiang First People's Hospital Intensive Care Unit in He’nan Province, Xinxiang 453000, China
[Abstract]Objective To investigate the effect of edaravone combined with Yuri Clinton treatment of acute cerebral infarction. Methods The control group on the basis of conventional treatment combined with edaravone, the research group in the conventional treatment based on give added edaravone urinary kallidinogenase combined treatment, record the clinical curative effect of two groups of patients, given the statistical analysis concluded. Results Clinical treatment in two groups of patients with acute cerebral infarction after different treatment methods, the study group, the total efficiency was 82.22% higher than the control group 66.67%, P>0.05, had difference statistically significance. Conclusion In the on the basis of routine treatment with edaravone and urinary kallidinogenase combined treatment can significantly improve acute cerebral infarction clinical curative effect, can reduce patient morbidity and mortality, ensuring the quality of life and life safety.
[Key words]Acute cerebral infarction, Edaravone, Urinary kallidinogenase, Treatment effect
急性脑梗死是临床常见的危重疾病,患者大多起病急、病情进展迅速、致残率及致死率较高,严重威胁生活质量及安全[1]。脑梗死属于现代社会中常见的多发病,尤其容易在中老年人群中发病,是严重危害人类生命健康的一种疾病。脑梗死的主要类型是急性脑梗死,急性脑梗死起病突然,临床症状主要表现为眩晕、头痛、耳鸣、呕吐、言语不清等。随病情的加重,可能出现昏迷,临床可经脑CT检查确诊。目前比较有效的急性脑梗死治疗方法是依达拉奉联合尤瑞克林,该疗法能够有效清除自由基,加强对脑部的保护作用。选取2013年1月1日~2013年12月31日于我院就诊的90例急性脑梗塞患者,探讨依达拉奉联合尤瑞克林治疗急性脑梗塞临床疗效,具体报告如下。……p>
